Canaccord Genuity Maintains Buy on BridgeBio Oncology, Lowers Price Target to $20
Canaccord Genuity analyst John Newman maintains BridgeBio Oncology (NASDAQ:BBOT) with a Buy and lowers the price target from $23 to $20.
News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Canaccord Genuity analyst John Newman maintains BridgeBio Oncology (NASDAQ:BBOT) with a Buy and lowers the price target from $23 to $20.
On July 27, 2026, CME expanded its equity product lineup with a new offering: Single Stock Futures, futures contracts on individual stocks that provide direct exposure to a company’s share price without requiring
UBS analyst Alex Kramm maintains Tradeweb Markets (NASDAQ:TW) with a Buy and lowers the price target from $150 to $145.
UBS analyst Dan Leonard maintains Stevanato Group (NYSE:STVN) with a Neutral and lowers the price target from $28 to $23.
https://www.apple.com/apple-events/event-stream/
Sergey Brin is taking a bigger role in Gemini from a converted Google microkitchen as Alphabet races to catch Anthropic and OpenAI.
GE HealthCare Technologies has submitted its next-generation StarGuide GX digital SPECT/CT system for FDA 510(k) clearance following CE Mark approval in Europe. The system features dual-sided CZT detectors, NVIDIA RTX computing, and rapid collimator exchange, designed to support emerging radioligand therapies including alpha emitters like Actinium-225 and Lead-212. Despite the regulatory milestone, GEHC stock declined 3% following the announcement.
Concrete Pumping (BBCP) has received positive analyst attention with upward earnings estimate revisions for both the current quarter and full year. The company is expected to earn $0.12 per share for the current quarter (up 33.3% year-over-year) and $0.19 for the full year (up 72.7% year-over-year). These improvements have earned the stock a Zacks Rank #2 (Buy) rating, with the stock already gaining 11.3% over the past four weeks.
Venture Global (VG), a liquid natural gas exporter, has received upward earnings estimate revisions from analysts. The company's current-quarter EPS is expected at $0.55 (+243.8% YoY) and full-year EPS at $1.63 (+89.5% YoY). With four positive estimate revisions in the past 30 days and no negative revisions, VG has earned a Zacks Rank #2 (Buy) rating. The stock has already gained 11.4% over the past four weeks, but analysts suggest further upside potential remains.
Solaris Energy Infrastructure (SEI) raised its 2026 Adjusted EBITDA guidance, with Q3 expectations up 23% and Q4 up 48% from previous midpoints, driven by stronger core power services and recent acquisitions of GESA and Omega Foundation Services. The company also initiated Q1 2027 guidance of $200-240 million, reflecting expansion into a broader full-cycle power infrastructure platform serving data centers and industrial markets.
PPL Corporation is expanding its clean-energy portfolio through wind, energy storage, and cleaner generation projects. The company's Rhode Island Energy unit secured 150 MW of renewable energy from a Maine wind project, while its Kentucky utilities are evaluating a 266-MW pumped-storage hydro project and exploring small modular reactors. PPL's $23 billion capital investment plan through 2029 targets 10.3% annual rate-base growth and 6-8% EPS growth.
Netflix stock has pulled back over 40% from its June 2025 record high of $133.91 to around $77, facing challenges including slowing revenue growth (expected 11.7% YoY in Q3), market saturation, negative free cash flow, and tough year-over-year comparisons from 2025 hits. However, the analyst views the pullback as a potential buying opportunity, noting Netflix's reasonable valuation at 21x next year's earnings, 300+ million subscribers, and expected 12% revenue and 22% EPS growth through 2028, though future gains likely won't match the past decade's 670% rally.
PepsiCo is recommended as a top dividend growth stock to buy in September. The company is a Dividend King with 54 years of consecutive dividend increases, currently offering a 4.3% yield. Despite underperforming the S&P 500 and trading down 14.3% over six months, PepsiCo's valuation is attractive relative to peers, making it an appealing opportunity for long-term dividend investors seeking stable income.
Accenture (ACN) is capitalizing on rising enterprise AI adoption with advanced AI bookings nearly doubling year-over-year and strong cash generation of $3.6B in Q3. The company plans $9B in acquisition spending for fiscal 2026 to expand AI and cybersecurity capabilities. However, risks include macro uncertainties affecting discretionary spending and execution challenges from accelerated acquisition activity.
Jack Henry & Associates (JKHY) receives a Superscore of 78/100, driven by record 58 core banking wins in fiscal 2026, $8.44 billion in remaining performance obligations, and 50% growth in faster-payments revenue. However, the stock trades at a stretched P/E of 22.7x, faces margin pressure from rising costs, and has limited AI differentiation. Despite current valuation concerns, analysts project 70% upside potential if the company maintains 7-8% earnings growth.
Amazon stock could potentially reach $600 per share by 2030, turning a $10,000 investment into over $23,000. The growth will be driven primarily by AWS, which is experiencing 37% year-over-year revenue growth and generating 60% of Amazon's operating income despite representing only 21% of revenue. AWS's expansion into AI and cloud computing infrastructure is expected to significantly increase Amazon's overall profit margins.
ServiceTitan stock plummeted 30% on Wednesday despite beating Q2 earnings and sales estimates, with strong AI product demand and raised full-year guidance. The sell-off was triggered by disappointing Q3 sales guidance that fell short of analyst expectations, though the company raised its full-year revenue and operating income targets.
Private equity firms are increasingly using AI to automate workflows. But as AI spending grows, LPs are wondering what they’re getting back.
UBS analyst Dan Leonard maintains Qiagen (NYSE:QGEN) with a Neutral and lowers the price target from $52 to $47.
In this episode of Capital Link’s Trending News Webinar, Mr. Pankaj Khanna, CEO of Heidmar Maritime Holdings (NASDAQ:HMR), joins Nicolas Bornozis, President of Capital Link, to discuss Heidmar’s Q2 performance, growth
Apple unveiled the iPhone 18 lineup, led by Pro models with a 2nm A20 Pro chip, upgraded Siri AI, better battery life and camera features.
https://www.apple.com/apple-events/event-stream/
UBS analyst Jay Sole maintains Children's Place (NASDAQ:PLCE) with a Neutral and lowers the price target from $4 to $3.25.
UBS analyst Doug Schenkel assumes Pacific Biosciences (NASDAQ:PACB) with a Neutral rating and lowers Price Target of $1.35.
Chevron aims to double Venezuela oil production to 600K bpd while driving cost efficiency in U.S. shale and expanding globally.
Apple unveils AirPods 5, Watch Ultra 4 and Series 12 with improved ANC, health tracking and battery life; prices start at $129, $799 and $399.
UBS analyst Lu Li maintains Myriad Genetics (NASDAQ:MYGN) with a Neutral and lowers the price target from $6 to $3.6.
https://www.apple.com/apple-events/event-stream/